Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

被引：201

作者：

Phillips, Elizabeth J. ^{[1
]}

Sukasem, Chonlaphat ^{[2
,3
]}

Whirl-Carrillo, Michelle ^{[4
]}

Mueller, Daniel J. ^{[5
,6
]}

Dunnenberger, Henry M. ^{[7
]}

Chantratita, Wasun ^{[8
,9
]}

Goldspiel, Barry ^{[10
]}

Chen, Yuan-Tsong ^{[11
,12
]}

Carleton, Bruce C. ^{[13
,14
]}

George, Alfred L. ^{[15
]}

Mushiroda, Taisei ^{[16
]}

Klein, Teri ^{[4
]}

Gammal, Roseann S. ^{[17
,18
]}

Pirmohamed, Munir ^{[19
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Pharmacogen & Personalized Med,Dept Pathol, Bangkok, Thailand

[3] Ramathibodi Hosp, Fac Med, Somdech Phra Debaratana Med Ctr, Lab Pharmacogen, Bangkok, Thailand

[4] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA

[5] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada

[6] Univ Toronto, Dept Psychiat & Pharmacol & Toxicol, Toronto, ON, Canada

[7] NorthShore Univ HealthSyst, Ctr Mol Med, Evanston, IL USA

[8] Mahidol Univ, Ramathibodi Hosp, Fac Med, Virol Lab,Dept Pathol, Bangkok, Thailand

[9] Mahidol Univ, Ramathibodi Hosp, Ctr Med Genom, Bangkok, Thailand

[10] NIH, Pharm Dept, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA

[11] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan

[12] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA

[13] Univ British Columbia, Fac Med, Dept Pediat, Div Translat Therapeut, Vancouver, BC, Canada

[14] BC Childrens Hosp, Res Inst, Vancouver, BC, Canada

[15] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA

[16] RIKEN, Ctr Integrat Med Sci, Lab Pharmacogen, Yokohama, Kanagawa, Japan

[17] MCPHS Univ, Dept Pharm Practice, Boston, MA USA

[18] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA

[19] Univ Liverpool, Dept Pharmacol, Liverpool, Merseyside, England

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷 / 04期

基金：

英国医学研究理事会; 加拿大创新基金会; 加拿大健康研究院; 美国国家卫生研究院;

关键词：

STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; ADVERSE DRUG-REACTIONS; CYTOTOXIC T-CELLS; HLA-B-ASTERISK-1502; ALLELE; B GENOTYPE; HYPERSENSITIVITY REACTIONS; CUTANEOUS REACTIONS; JAPANESE PATIENTS; THAI POPULATION;

D O I：

10.1002/cpt.1004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The variant allele HLA-B*15:02 is strongly associated with greater risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in patients treated with carbamazepine or oxcarbazepine. The variant allele HLA-A*31:01 is associated with greater risk of maculopapular exanthema, drug reaction with eosinophilia and systemic symptoms, and SJS/TEN in patients treated with carbamazepine. We summarize evidence from the published literature supporting these associations and provide recommendations for carbamazepine and oxcarbazepine use based on HLA genotypes.

引用

页码：574 / 581

页数：8

共 40 条

[31] Drug hypersensitivity: Pharmacogenetics and clinical syndromes [J].